Close Menu

NEW YORK – The US Food and Drug Administration cleared in vitro diagnostic tests and systems in July from Becton Dickinson, Siemens Healthineers, Abbott, Roche, and others, according to the agency's website.

Siemens Healthineers received clearance for the Atellica CH Amylase 2 assay running on the firm's Atellica CH Analyzer to measure amylase activity in serum, plasma, and urine and to diagnose and monitor acute pancreatitis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.